Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-remifentanil versus propofol-remifentanil for sedation during plastic surgery
ChiCTR-IPR-17012825Phase 4Completed
- Sponsor
- Plastic Surgery Hospital of Chinese Academy of Medical Sciences
- Start
- Oct 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine, remifentanil and propofol in None (2 arms), sponsored by Plastic Surgery Hospital of Chinese Academy of Medical Sciences. Primary endpoints: blood oxygen saturation, respiratory rate and 3 more. Started Oct 2017; status: completed.
02
Drugs
dexmedetomidineremifentanilpropofol
Beyond the preview
Go deeper on ChiCTR-IPR-17012825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17012825.